2025年4月27日 周日
Home > Archive>Volume 29, Issue 10, 2021 >913-916
PDF HTML XML Export Cite reminder
Research progress on the mechanism of serum amyloid A promoting atherosclerosis
Author:
Affiliation:

Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China)

Clc Number:

R541.4

  • Article
    • | |
  • Metrics
    • |
  • Reference [25]
    • | |
  • Cited by
    • | |
  • Comments
    Abstract:

    Serum amyloid A has a significant effect on the formation of atherosclerosis as an acute reaction, leading to inflammation by stimulating the release of inflammation factors. It is vital for atherosclerosis that serum amyloid A combined with lipoprotein changes the physiological function of high density lipoprotein. Serum amyloid A can affect the function of vascular endothelium and smooth muscle, and also cause thrombosis,which all promote the development of atherosclerosis.

    Reference
    [1] LORENZATTI A, SERVATO M L.Role of anti-inflammatory interventions in coronary artery disease:understanding the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).Eur Cardiol, 8,3(1):38-41.
    [2] DE BUCK M, GOUWY M, STRUYF S, et al.The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round.Immunol Lett, 9,5:1-8.
    [3] VALLEJO A, CHAMI B, DENNIS J M, et al.NF-κB inhibition mitigates serum amyloid A-induced pro-atherogenic responses in endothelial cells and leukocyte adhesion and adverse changes to endothelium function in isolated aorta.Int J Mol Sci, 8,0(1):105.
    [4] CHENG N, LIANG Y, DU X, et al.Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury.EMBO Rep, 8,9(10):e45517.
    [5] YU M H, LI X, LI Q, et al.SAA1 increases NOX4/ROS production to promote LPS-induced inflammation in vascular smooth muscle cells through activating p38 MAPK/NF-κB pathway.BMC Mol Cell Biol, 9,0(1):15.
    [6] RIDKER P M, MACFADYEN J G, THUREN T, et al.Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab:further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis.Eur Heart J, 0,1(23):2153-2163.
    [7] ZHANG X, CHEN J, WANG S.Serum amyloid a induces a vascular smooth muscle cell phenotype switch through the p38 MAPK signaling pathway.Biomed Res Int, 2017(4941379):4941379.
    [8] THOMPSON J C, JAYNE C, THOMPSON J, et al.A brief elevation of serum amyloid A is sufficient to increase atherosclerosis.J Lipid Res, 5,6(2):286-293.
    [9] SHRIDAS P, TANNOCK L R.Role of serum amyloid A in atherosclerosis.Curr Opin Lipidol, 9,0(4):320-325.
    [10] CAI X, AHMAD G, HOSSAIN F, et al.High-density lipoprotein (HDL) inhibits serum amyloid a (SAA)-induced vascular and renal dysfunctions in apolipoprotein E-deficient mice.Int J Mol Sci, 0,1(4):1316.
    [11] JI A, WANG X, NOFFSINGER V P, et al.Serum amyloid A is not incorporated into HDL during HDL biogenesis.J Lipid Res, 0,1(3):328-337.
    [12] WILSON P G, THOMPSON J C, SHRIDAS P, et al.Serum amyloid a is an exchangeable apolipoprotein.Arterioscler Thromb Vasc Biol, 8,8(8):1890-1900.
    [13] TANNOCK L R, DE BEER M C, JI A, et al.Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein.J Lipid Res, 8,9(2):339-347.
    [14] 莫中成, 唐朝克.胆固醇逆向转运关键蛋白介导药物和小分子调控脂代谢的机制研究.中国动脉硬化杂志, 8,6(4):325-328.
    [15] HAN C Y, KANG I, OMER M, et al.Serum amyloid A-containing HDL binds adipocyte-derived versican and macrophage-derived biglycan, reducing its antiinflammatory properties.JCI Insight, 0,5(20):142635.
    [16] CAO J, XU Y, LI F, et al.Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice.J Transl Med, 8,6(1):155.
    [17] 曹佳, 刘发权, 喻红.HDL功能检测与冠状动脉斑块的相关性.中国动脉硬化杂志, 8,6(10):1045-1051.
    [18] JAYARAMAN S, HAUPT C, GURSKY O.Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA.J Lipid Res, 6,7(12):2138-2149.
    [19] TSUNODA F, LAMON-FAVA S, HORVATH K V, et al.Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins.Lipids Health Dis, 6,5(1):163.
    [20] TRAKAKI A, SCHARNAGL H, TRIEB M, et al.Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity.Sci Rep, 0,0(1):15001.
    [21] FERNNDEZ J A, DEGUCHI H, ELIAS D J, et al.Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients.Res Pract Thromb Haemost, 0,4(2):217-223.
    [22] ABUDUHALIKE R, SUN J, ZHAO L, et al.Correlation study of venous thromboembolism with SAA, IL-1, and TNF-α levels and gene polymorphisms in Chinese population.J Thorac Dis, 9,1(12):5527-5534.
    [23] BLANK N, HEGENBART U, DIETRICH S, et al.Obesity is a significant susceptibility factor for idiopathic AA amyloidosis.Amyloid, 8,5(1):37-45.
    [24] MILLER A L, KACIROTI N, STURZA J, et al.Associations between stress biology indicators and overweight across toddlerhood.Psychoneuroendocrinology, 7,9:98-106.
    [25] YANG R Z, LEE M J, HU H, et al.Acute-phase serum amyloid A:an inflammatory adipokine and potential Link between obesity and its metabolic complications.PLoS Med, 6,3(6):e287.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

XIA Kexin, LIU Haixia. Research progress on the mechanism of serum amyloid A promoting atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2021,29(10):913-916.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 26,2020
  • Revised:April 02,2021
  • Online: October 13,2021
Article QR Code

You are the 36279 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025